Currently, there is no convincing evidence supporting glucose control or lifestyle management as therapies for neuropathic pain in DM or prediabetes
Compounded drugs: Questions and answers
Digital health companies are uniquely positioned to deliver this kind of careflexible, accessible, and affordable
During the first week on semaglutide GLP-1 , most people notice changes in appetite before anything else
Serious but less common risks include pancreatitis, gallbladder problems, dehydration from severe vomiting or diarrhoea, worsening diabetic eye disease in some patients with rapid glucose improvement, and allergic reactions
Dutta pointed to the approach for managing other chronic diseases as further evidence of why adjunctive therapies should be approved in type 1 diabetes